- Report
- August 2018
- 86 Pages
Global
From €9500EUR$10,000USD£8,146GBP
- Report
- August 2018
- 94 Pages
Global
From €9500EUR$10,000USD£8,146GBP
- Report
- January 2024
- 95 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- October 2023
- 74 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- June 2023
- 91 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- May 2023
- 103 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- May 2023
- 102 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- April 2023
- 108 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- January 2021
- 149 Pages
China, Global
From €3000EUR$3,383USD£2,663GBP
- Report
- January 2021
- 146 Pages
China, Global
From €3000EUR$3,383USD£2,663GBP
- Report
- January 2021
- 138 Pages
China, Global
From €3000EUR$3,383USD£2,663GBP
- Report
- January 2021
- 139 Pages
China, Global
From €3000EUR$3,383USD£2,663GBP
- Report
- February 2024
- 77 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- January 2024
- 75 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- January 2024
- 96 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- January 2024
- 93 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- September 2023
- 89 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- June 2023
- 80 Pages
Global
From €3500EUR$3,946USD£3,106GBP
The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more